相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Eligibility, compliance and persistence of extended adjuvant endocrine therapy for breast cancer
Mary E. Myrick et al.
ACTA ONCOLOGICA (2012)
Deep Time: The Long and the Short of Adjuvant Endocrine Therapy for Breast Cancer
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment Crossover
Huan Jin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer
Susan F. Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Patient adherence to aromatase inhibitor treatment in the adjuvant setting
S. Verma et al.
Current Oncology (2011)
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S. Albain et al.
LANCET ONCOLOGY (2010)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Simultaneous inference in general parametric models
Torsten Hothorn et al.
BIOMETRICAL JOURNAL (2008)
Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions
Paul E. Goss et al.
CLINICAL BREAST CANCER (2008)
A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer
Xiao-Jun Ma et al.
CLINICAL CANCER RESEARCH (2008)
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen
Paul E. Goss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical application of the 70-gene profile: The MINDACT trial
Fatima Cardoso et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Letrozole in the extended adjuvant setting: MA.17
Paul E. Goss
BREAST CANCER RESEARCH AND TREATMENT (2007)
The HOXB13:IL7BR expression index is a prognostic factor in early-stage breast cancer
Xiao-Jun Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen
MP Goetz et al.
CLINICAL CANCER RESEARCH (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCICCTG MA.17
PE Goss et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
PE Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
